What Analysts Are Saying About WAVE Life Sciences Stock
What Analysts Are Saying About WAVE Life Sciences Stock
關於Wave Life Sciences股票的分析師意見
During the last three months, 4 analysts shared their evaluations of WAVE Life Sciences (NASDAQ:WVE), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，4位分析師分享了他們對創業板（NASDAQ:WVE）的評估，展現了從看好到看淡的不同觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $15.5, a high estimate of $19.00, and a low estimate of $11.00. Observing a downward trend, the current average is 8.82% lower than the prior average price target of $17.00.
通過對12個月價格目標的評估，分析師提供了更深入的見解，揭示了平均目標價爲15.5美元，最高估計爲19.00美元，最低估計爲11.00美元的價格目標。經過觀察發現，當前的平均目標價比之前的17.00美元的平均目標價降低了8.82%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探討分析師評級：分析師評級的深度探討
The standing of...
通過對...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。